Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cytosorbents (CTSO) Short-term Investments (2016 - 2024)

Cytosorbents (CTSO) has disclosed Short-term Investments for 3 consecutive years, with $5.0 million as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Short-term Investments changed N/A year-over-year to $5.0 million, compared with a TTM value of $5.0 million through Dec 2024, changed N/A, and an annual FY2024 reading of $5.0 million, changed N/A over the prior year.
  • Short-term Investments was $5.0 million for Q4 2024 at Cytosorbents, up from $249000.0 in the prior quarter.
  • Across five years, Short-term Investments topped out at $5.0 million in Q4 2024 and bottomed at $5.0 million in Q4 2024.